Invitrogen™ RNaseOUT™ Recombinant Ribonuclease Inhibitor

Protects mRNA and improves total cDNA yields

Supplier:  Invitrogen™ 10777019

Catalog No. 10-777-019

Description

RNaseOUT Recombinant Ribonuclease Inhibitor is a potent noncompetitive inhibitor of pancreatic-type ribonucleases such as RNase A, and is used to avoid RNA degradation in a variety of applications. RNaseOUT Recombinant Ribonuclease Inhibitor is an acidic protein with a molecular weight of approx. 52 kDa. RNaseOUT inhibits RNase A, RNase B, and RNase C.
Applications cDNA synthesis, RT-PCR, and in vitro transcription and translation
Source Purified by affinity chromatography from E. coli expressing a cloned porcine gene
Performance and quality testing SDS-PAGE purity, endodeoxyribonuclease assay, protein concentration, specific activity, performance evaluated by RT-PCR
Unit definition One unit inhibits 5 ng of RNase A by 50% using cytidine 2', 3' cyclic monophosphate (cCMP) as the substrate
Unit reaction conditions 100mM Tris-acetate (pH 6.5), 1mM EDTA, 0.2mM cCMP, 2 μg RNase A in 1mL from 0 to 10 min at 25°C

PCR and Real-Time PCR, Reverse Transcription

Order Info

Shipping Condition: Dry ice

Specifications

• Concentration: 100 mM
• Purification Time: 10 min.
• Shipping Condition: Dry Ice

• Content And Storage: Store at -20°C. Avoid exposing product to frequent changes in temperature. RNaseOUT™ Ribonuclease Inhibitor requires 1 mM DTT to maintain activity.
  
  The product is guaranteed for 6 months from date of purchase unless otherwise stated in the product documentation.
• Product Line: RNaseOUT™

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov

For Research Use Only. Not for use in diagnostic procedures.